glp-1 receptor agonists in pediatric and adolescent obesity Role of Obesity: Benefits, Risks, Approaches to Patient Selection | Current Reports Efficacy and safety of GLP-1

Published 2016 Nov 23

Researchers observed that this orexigenic effect distinguishes GHRP-6 from more selective secretagogues like ipamorelin, which releases GH with minimal appetite stimulation

A large study that compared tirzepatide to semaglutide showed that in non-diabetic, overweight adults, the risk of gastroparesis was much higher in semaglutide recipients compared to tirzepatide

These pharmacokinetic data allow a once-weekly subcutaneous injection regimen

Our preliminary interpretation is that replacement of Tyr110 indeed affects the interaction with GSH but, as compared to K105A/Y, does not drastically alter the ratio between the steady-state concentrations of the deprotonated and glutathionylated enzyme species E and F, respectively